StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.67−0.15 (-3.11%)

Close on Nov 17, 2026Market cap $364.00MP/E –Yield –

CorMedix price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

CorMedix's price to book ratio was 0.9× on Nov 11, 2026, against 2.1× a year earlier. Over the last 5 years it ranged from 0.9× to 12.0×, with a median of 3.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×−1.5
2025Dec 31, 20252.4×−5.6
2024Dec 31, 20248.0×+5.5
2023Dec 29, 20232.5×−0.6
2022Dec 30, 20223.1×+0.6
2021Dec 31, 20212.5×−4.3
2020Dec 31, 20206.8×+0.3
2019Dec 31, 20196.5×−285.4
2018Jul 31, 2018291.9×+275.8
2017Dec 29, 201716.0×+3.0
2016Dec 30, 201613.0×+3.1
2015Dec 31, 20159.9×−28.4
2014Dec 31, 201438.2×+7.2
2012Jul 31, 201231.0×+9.4
2011Dec 30, 201121.6×–

More CorMedix figures

See a number that looks wrong?